Cancer Frontline | MD Anderson Cancer Center Skip to Content
Top

BY Ron Gilmore

The American Association for Cancer Research (AACR) has selected Isaiah J. Fidler, D.V.M., Ph.D., professor of Cancer Biology, as recipient of this year’s Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

The award was presented to Fidler on April 15 in Chicago at the AACR’s annual meeting.

In cancer firsts, Fidler and Margaret Kripke, Ph.D., MD Anderson professor emerita of Immunology...

Isaiah J. Fidler, D.V.M., Ph.D., received this year’s Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

BY Scott Merville

Melanoma cells are able to evade cancer immunotherapy by using a specific protein to hide from immune system T cells out to seek and destroy...

BY Ronda Wendler

When people breathe, there’s movement inside their bodies.

Organs, tissues and even cancer patients’ tumors move around all the time...

BY Ron Gilmore

MD Anderson was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30% of the $73.5 million in awards CPRIT announced in February. The awards included $16.3 million for individual investigator research including awards for cancer in children and adolescents, computational biology, clinical translation, and prevention and early detection. MD Anderson also received $2 million for recruitment...

BY Clayton Boldt, Ph.D.

MD Anderson’s Colorectal Cancer Moon Shot™ is committed to the prevention and early detection of the third most common cancer diagnosed in...

BY Ron Gilmore

Cell-based immunotherapies such as chimeric antigen receptors (CAR T), T-cell receptor (TCR) engineered T cells, tumor-infiltrating lymphocytes...

BY Bryan Tutt

Radiation therapy to the whole breast or chest wall and the internal mammary lymph nodes can deliver a radiation dose to the heart that increases...

BY Scott Merville

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal...

BY Scott Merville

A cold virus engineered to attack the most common and deadly of brain tumors allowed 20% of patients with recurrent glioblastoma to live for...

BY Scott Merville

Organizations in Spain and Saudi Arabia recognized the leadership of Jim Allison, Ph.D., MD Anderson chair of Immunology, in cultivating the...